Roberto Matía
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roberto Matía has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Hernández Madrid
Arrhythmia Unit, Cardiology Department, Ramón y Cajal Hospital, Alcalá University, Madrid, Spain
9 shared publications Javier Moreno
Arrhythmia Unit, Cardiology Department, Ramon y Cajal Hospital, Madrid, Spain
4 shared publicationsAntonio Hernández-Madrid
Hospital Universitario "Ramón y Cajal" de Madrid, Spain
3 shared publications- Eduardo Franco
Ramón y Cajal University Hospital, Madrid, Spain
3 shared publications Inmaculada Sánchez
Pediatric Cardiology Department, University Hospital Ramón y Cajal, Madrid, Spain
3 shared publications- Aurelio Quesada
Arrhythmia Unit, Cardiology Department, General University Hospital Consortium of Valencia, 46014 Valencia, Spain
2 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 10, e86621
Generation of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study
Background: Smartwatches have significantly expanded personal health monitoring capabilities; however, their application in comprehensive cardiac assessment remains limited by single-lead electrocardiogram (ECG) acquisition. The inability to directly obtain augmented limb leads represents a major limitation for the evaluation of ischemic and arrhythmogenic conditions. Objective: This study aimed to present and preliminarily evaluate a methodology for generating augmented limb leads (augmented voltage right [aVR], augmented voltage left [aVL], and augmented voltage foot [aVF]) from sequential smartwatch recordings through signal synchronization and RR interval alignment, and to combine this approach with precordial smartwatch recordings to reconstruct a full 12-lead ECG in a proof-of-concept setting. Methods: A signal-processing framework was developed to preserve ECG morphology across sequential smartwatch lead recordings. The method is based on RR interval–guided temporal resampling, enabling interlead synchronization and analytical reconstruction of augmented limb leads. A prospective proof-of-concept clinical validation was conducted in 20 cases with diverse cardiac pathologies, including 1 healthy control. Smartwatch-derived ECGs were compared with standard 12-lead ECGs. Evaluation included expert-based clinical interpretation by 85 health care professionals and objective quantitative analysis of key electrocardiographic parameters, including heart rate, PR interval, QRS duration, QT interval, QTc, RR interval, P-wave duration, and PP interval. Mean values, SDs, and intermethod differences were calculated to assess agreement and variability. Results: Reconstruction of a 12-lead ECG from smartwatch-acquired signals was successfully achieved in all cases. Visual correlation scores between smartwatch-derived and conventional ECGs ranged from 78.1% to 91.3% across specialty-level means (mean 81.1, SD 22.7), indicating high perceived concordance; individual case-level scores ranged more widely, from 47.0% to 96.3%. Evaluator-perceived axis agreement reached 95.4% across all cases, while the investigators’ direct axis measurements showed complete concordance in all cases. Quantitative analysis demonstrated small mean differences between modalities, with particularly high agreement observed in structurally stable parameters such as heart rate (mean 77.2, SD 22.3 vs mean 75.9, SD 23.1 bpm; Δ=1.3 bpm) and PR interval (mean 176.2, SD 29.1 vs mean 180.8, SD 19.8 ms; Δ=−4.6 ms). Greater variability was observed in atrial activation parameters such as P-wave duration (Δ=−13.3 ms) and time-dependent parameters such as QT (Δ=−19.2 ms) and QTc (Δ=−12.7 ms). Conclusions: This proof-of-concept study demonstrates the feasibility of reconstructing a full 12-lead ECG from smartwatch-derived signals using a synchronization-based approach. The results demonstrated generally small mean differences between conventional and smartwatch-derived ECG measurements, although larger interval differences were observed in some individual cases. Importantly, due to the sequential nature of signal acquisition, the proposed methodology does not aim to achieve direct waveform equivalence but rather clinically meaningful agreement in electrocardiographic parameters. These findings support the potential of smartwatches as accessible tools for advanced cardiac monitoring and broaden their applicability beyond single-lead screening.
- 5 November 2026
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 10, e86621
Open AccessGeneration of 12-Lead Electrocardiogram Using Smartwatches in Patients With Cardiac Conditions: Clinical Validation Study
Background: Smartwatches have significantly expanded personal health monitoring capabilities; however, their application in comprehensive cardiac assessment remains limited by single-lead electrocardiogram (ECG) acquisition. The inability to directly obtain augmented limb leads represents a major limitation for the evaluation of ischemic and arrhythmogenic conditions. Objective: This study aimed to present and preliminarily evaluate a methodology for generating augmented limb leads (augmented voltage right [aVR], augmented voltage left [aVL], and augmented voltage foot [aVF]) from sequential smartwatch recordings through signal synchronization and RR interval alignment, and to combine this approach with precordial smartwatch recordings to reconstruct a full 12-lead ECG in a proof-of-concept setting. Methods: A signal-processing framework was developed to preserve ECG morphology across sequential smartwatch lead recordings. The method is based on RR interval–guided temporal resampling, enabling interlead synchronization and analytical reconstruction of augmented limb leads. A prospective proof-of-concept clinical validation was conducted in 20 cases with diverse cardiac pathologies, including 1 healthy control. Smartwatch-derived ECGs were compared with standard 12-lead ECGs. Evaluation included expert-based clinical interpretation by 85 health care professionals and objective quantitative analysis of key electrocardiographic parameters, including heart rate, PR interval, QRS duration, QT interval, QTc, RR interval, P-wave duration, and PP interval. Mean values, SDs, and intermethod differences were calculated to assess agreement and variability. Results: Reconstruction of a 12-lead ECG from smartwatch-acquired signals was successfully achieved in all cases. Visual correlation scores between smartwatch-derived and conventional ECGs ranged from 78.1% to 91.3% across specialty-level means (mean 81.1, SD 22.7), indicating high perceived concordance; individual case-level scores ranged more widely, from 47.0% to 96.3%. Evaluator-perceived axis agreement reached 95.4% across all cases, while the investigators’ direct axis measurements showed complete concordance in all cases. Quantitative analysis demonstrated small mean differences between modalities, with particularly high agreement observed in structurally stable parameters such as heart rate (mean 77.2, SD 22.3 vs mean 75.9, SD 23.1 bpm; Δ=1.3 bpm) and PR interval (mean 176.2, SD 29.1 vs mean 180.8, SD 19.8 ms; Δ=−4.6 ms). Greater variability was observed in atrial activation parameters such as P-wave duration (Δ=−13.3 ms) and time-dependent parameters such as QT (Δ=−19.2 ms) and QTc (Δ=−12.7 ms). Conclusions: This proof-of-concept study demonstrates the feasibility of reconstructing a full 12-lead ECG from smartwatch-derived signals using a synchronization-based approach. The results demonstrated generally small mean differences between conventional and smartwatch-derived ECG measurements, although larger interval differences were observed in some individual cases. Importantly, due to the sequential nature of signal acquisition, the proposed methodology does not aim to achieve direct waveform equivalence but rather clinically meaningful agreement in electrocardiographic parameters. These findings support the potential of smartwatches as accessible tools for advanced cardiac monitoring and broaden their applicability beyond single-lead screening.
- Open Access
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Subjective identification and ablation of drivers in persistent atrial fibrillation
Background: Ablation of drivers in persistent atrial fibrillation (AF) has shown controversial results. Purpose: To test the efficacy of a tailored approach for persistent AF ablation which includes pulmonary vein isolation (PVI) plus “subjective” identification and ablation of drivers. Methods: From May 2017 to December 2019, selected patients with persistent AF and ongoing AF at the beginning of the ablation procedure were included. Conventional high-density mapping catheters (PentaRay NAV, IntellaMap Orion or Advisor HD Grid) were used. Drivers were subjectively identified as: a) fractionated continuous (or quasi-continuous) electrograms on 1–2 adjacent bipoles, without dedicated software (Figure 1A, dashed line; PR = PentaRay NAV); and b) sites with spatiotemporal dispersion (i.e. all the cycle length comprised within the mapping catheter) plus non-continuous fractionation on single bipoles (Figure 1B, arrows; in panels A and B: paper speed 200 mm/s; ORB = 24-pole ORBITER Woven catheter, blue bipoles around tricuspid annulus and green bipoles into the coronary sinus). Ablation included PVI + focal or linear ablation targeting sites with drivers. Ablation success was defined as conversion to sinus rhythm or atrial flutter during ablation. Follow-up included visits with 24h Holter ECG at 3–6–12 months. Survival free from atrial arrhythmias lasting >30 seconds was compared between patients ablated with this tailored approach, and all consecutive patients with persistent AF treated with a PVI-only strategy during the same period. Results: 158 Patients received ablation: 35 with the tailored approach (61,7±10,2 years; 29% females) and 123 with only PVI (62,5±9,6 years; 25% females; 89% cryoablation). Basal characteristics were similar (Table 1). In the tailored-approach group, 14 patients (40%) presented 28 detectable sites with continuous fractionated electrograms, 26 on the left atrium and 2 on the right atrium, which was only mapped if ablation of drivers in the left atrium was not successful; 12 (43%) were located within the pulmonary vein antra. 27 patients (77%) showed 103 sites with spatiotemporal dispersion (4 [3–5] per patient). Ablation success was achieved in 17 patients (48%; conversion to sinus rhythm, n=7; conversion to atrial flutter, n=10) in the tailored-approach group and 1 patient (0,8%, sinus rhythm) in the PVI-only group. Excluding a 3-month blanking period, the tailored approach, compared to only PVI, improved one-year freedom from atrial arrhythmias (71% Vs 51%, p=0,05) and mean survival free from atrial arrhythmias (26±3 months; 95% CI 21–32 months Vs 18±2 months; 95% CI 15–22 months) (Figure 1C), at the cost of a longer median procedural time (246 [212–277] vs 108 [81–143] min, p<0,001) and fluoroscopy time (51 [36–76] vs 33 [21–45] min, p<0,001). Conclusion: Subjective identification and ablation of drivers, added to PVI, improved freedom from atrial arrhythmias. Funding Acknowledgement: Type of funding sources: None. Table 1. Basal characteristicsFigure 1
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Open AccessSubjective identification and ablation of drivers in persistent atrial fibrillation
Background: Ablation of drivers in persistent atrial fibrillation (AF) has shown controversial results. Purpose: To test the efficacy of a tailored approach for persistent AF ablation which includes pulmonary vein isolation (PVI) plus “subjective” identification and ablation of drivers. Methods: From May 2017 to December 2019, selected patients with persistent AF and ongoing AF at the beginning of the ablation procedure were included. Conventional high-density mapping catheters (PentaRay NAV, IntellaMap Orion or Advisor HD Grid) were used. Drivers were subjectively identified as: a) fractionated continuous (or quasi-continuous) electrograms on 1–2 adjacent bipoles, without dedicated software (Figure 1A, dashed line; PR = PentaRay NAV); and b) sites with spatiotemporal dispersion (i.e. all the cycle length comprised within the mapping catheter) plus non-continuous fractionation on single bipoles (Figure 1B, arrows; in panels A and B: paper speed 200 mm/s; ORB = 24-pole ORBITER Woven catheter, blue bipoles around tricuspid annulus and green bipoles into the coronary sinus). Ablation included PVI + focal or linear ablation targeting sites with drivers. Ablation success was defined as conversion to sinus rhythm or atrial flutter during ablation. Follow-up included visits with 24h Holter ECG at 3–6–12 months. Survival free from atrial arrhythmias lasting >30 seconds was compared between patients ablated with this tailored approach, and all consecutive patients with persistent AF treated with a PVI-only strategy during the same period. Results: 158 Patients received ablation: 35 with the tailored approach (61,7±10,2 years; 29% females) and 123 with only PVI (62,5±9,6 years; 25% females; 89% cryoablation). Basal characteristics were similar (Table 1). In the tailored-approach group, 14 patients (40%) presented 28 detectable sites with continuous fractionated electrograms, 26 on the left atrium and 2 on the right atrium, which was only mapped if ablation of drivers in the left atrium was not successful; 12 (43%) were located within the pulmonary vein antra. 27 patients (77%) showed 103 sites with spatiotemporal dispersion (4 [3–5] per patient). Ablation success was achieved in 17 patients (48%; conversion to sinus rhythm, n=7; conversion to atrial flutter, n=10) in the tailored-approach group and 1 patient (0,8%, sinus rhythm) in the PVI-only group. Excluding a 3-month blanking period, the tailored approach, compared to only PVI, improved one-year freedom from atrial arrhythmias (71% Vs 51%, p=0,05) and mean survival free from atrial arrhythmias (26±3 months; 95% CI 21–32 months Vs 18±2 months; 95% CI 15–22 months) (Figure 1C), at the cost of a longer median procedural time (246 [212–277] vs 108 [81–143] min, p<0,001) and fluoroscopy time (51 [36–76] vs 33 [21–45] min, p<0,001). Conclusion: Subjective identification and ablation of drivers, added to PVI, improved freedom from atrial arrhythmias. Funding Acknowledgement: Type of funding sources: None. Table 1. Basal characteristicsFigure 1
- Open Access
- 1 April 2017
- Published by Elsevier in Heart Rhythm
- Vol. 14 (4) , 541-547
Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLÉ CRT) study
- 1 April 2017
- Published by Elsevier in Heart Rhythm
- Vol. 14 (4) , 541-547
Open AccessDevice pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLÉ CRT) study
- 4 May 2016
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 39 (7) , 633-641
An Automatic Algorithm Based on Morphological Stability During Fast Ventricular Arrhythmias Predicts Successful Antitachycardia Pacing in ICD Patients: A Multicenter Study
Different types of ventricular arrhythmias (monomorphic VT, polymorphic VT or ventricular fibrillation) can be detected by implantable cardiac defibrillators in fast VT zone. The efficacy of antitachycardia pacing (ATP) depends on the type of the treated arrhythmia. We hypothesized that an automatic algorithm based on morphological affinity of ICD far-field electrograms during tachycardia can predict ATP success and the need of shock.The algorithm was evaluated on ventricular arrhythmias recorded in Carelink ICD remote monitoring system. Patients were selected if first ATP programmed was a burst of 8 pulses at 88% coupling interval and if a far-field electrogram was available. The algorithm calculated a stability coefficient (SC) for all their stored ATP-treated fast VA episodes (LC 200-300 msec.), analyzing the morphology homogeneity of the last 8 recorded far-field electrograms before ventricular arrhythmias detection.Inclusion criteria were fulfilled by 717 patients from 29 centers. Three hundred and twenty fast VA were recorded in 103 patients. A higher SC was observed in episodes terminated with the first-ATP [0.78 (0.72-0.84) vs 0.74 (0.60-0.84); P = 0.006]. These differences were especially marked among the 62 episodes of very fast VA (CL ≤250 msec.) [0.77 (0.74-0.85) vs 0.64 (0.51-0.8); P = 0.006]. In the multivariate analysis, a SC>70% was independently associated with a higher likelihood of first-ATP success (OR = 2.5; [95% CI = 1.4-4.5], P = 0.001) and a lower need of shock (OR = 0.37; [95% CI = 0.2-0.7], P = 0.002).This automatic algorithm (Stability coefficient) shows that ATP therapy response can be predicted in fast ventricular arrhythmias through morphology evaluation. This article is protected by copyright. All rights reserved.
- 4 May 2016
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 39 (7) , 633-641
An Automatic Algorithm Based on Morphological Stability During Fast Ventricular Arrhythmias Predicts Successful Antitachycardia Pacing in ICD Patients: A Multicenter Study
Different types of ventricular arrhythmias (monomorphic VT, polymorphic VT or ventricular fibrillation) can be detected by implantable cardiac defibrillators in fast VT zone. The efficacy of antitachycardia pacing (ATP) depends on the type of the treated arrhythmia. We hypothesized that an automatic algorithm based on morphological affinity of ICD far-field electrograms during tachycardia can predict ATP success and the need of shock.The algorithm was evaluated on ventricular arrhythmias recorded in Carelink ICD remote monitoring system. Patients were selected if first ATP programmed was a burst of 8 pulses at 88% coupling interval and if a far-field electrogram was available. The algorithm calculated a stability coefficient (SC) for all their stored ATP-treated fast VA episodes (LC 200-300 msec.), analyzing the morphology homogeneity of the last 8 recorded far-field electrograms before ventricular arrhythmias detection.Inclusion criteria were fulfilled by 717 patients from 29 centers. Three hundred and twenty fast VA were recorded in 103 patients. A higher SC was observed in episodes terminated with the first-ATP [0.78 (0.72-0.84) vs 0.74 (0.60-0.84); P = 0.006]. These differences were especially marked among the 62 episodes of very fast VA (CL ≤250 msec.) [0.77 (0.74-0.85) vs 0.64 (0.51-0.8); P = 0.006]. In the multivariate analysis, a SC>70% was independently associated with a higher likelihood of first-ATP success (OR = 2.5; [95% CI = 1.4-4.5], P = 0.001) and a lower need of shock (OR = 0.37; [95% CI = 0.2-0.7], P = 0.002).This automatic algorithm (Stability coefficient) shows that ATP therapy response can be predicted in fast ventricular arrhythmias through morphology evaluation. This article is protected by copyright. All rights reserved.
- 12 February 2016
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 27 (4) , 482-487
Wireless Ultrasound‐Guided Axillary Vein Cannulation for the Implantation of Cardiovascular Implantable Electric Devices
Wireless Ultrasound‐Guided Axillary Vein Cannulation: Introduction: Ultrasound guidance for vascular cannulation seems safer and more effective than an anatomical landmark approach, though it has not gained widespread support partly due to workflow interference of wired probes. A wireless ultrasound transducer (WUST) may overcome this issue. We report the effectiveness, time consumption, and safety of the first‐in‐human experience in axillary vein cannulation guided with a novel WUST for the implantation of cardiovascular implantable electric devices (CIEDs).Methods and Results: After a one‐month training period, we routinely performed WUST‐guided puncture to all first implants, prospectively registering data from the first 50 patients. We analyzed the time needed for preparing the WUST and for achieving each vein cannulation, and the rate of unsuccessful or accidental arterial punctures and complications. WUST‐guided axillary vein access was successful in 49 out of 50 patients, totaling 86 cannulated veins. Median WUST preparation time was 55 [44–62] seconds and median time needed for each venous cannulation was 56 [36–71] seconds. A total of 84.9% of the veins were cannulated at the first attempt. There were 7 unsuccessful puncture attempts and 1 accidental arterial puncture. No pneumothorax, hemothorax, or nervous injury occurred in the 49 successfully cannulated patients. The unsuccessful one (distal subclavian occlusion) developed a minor local subcutaneous emphysema with no confirmed radiologic pneumothorax, not requiring intervention. During a follow‐up of 2.5 ± 1.1 months, a patient developed a pocket infection, with no other significant complications.Conclusion: Ultrasound‐guided axillary vein cannulation using a wireless transducer for the implantation of CIEDs is a feasible, fast, and safe method.
- 12 February 2016
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 27 (4) , 482-487
Wireless Ultrasound‐Guided Axillary Vein Cannulation for the Implantation of Cardiovascular Implantable Electric Devices
Wireless Ultrasound‐Guided Axillary Vein Cannulation: Introduction: Ultrasound guidance for vascular cannulation seems safer and more effective than an anatomical landmark approach, though it has not gained widespread support partly due to workflow interference of wired probes. A wireless ultrasound transducer (WUST) may overcome this issue. We report the effectiveness, time consumption, and safety of the first‐in‐human experience in axillary vein cannulation guided with a novel WUST for the implantation of cardiovascular implantable electric devices (CIEDs).Methods and Results: After a one‐month training period, we routinely performed WUST‐guided puncture to all first implants, prospectively registering data from the first 50 patients. We analyzed the time needed for preparing the WUST and for achieving each vein cannulation, and the rate of unsuccessful or accidental arterial punctures and complications. WUST‐guided axillary vein access was successful in 49 out of 50 patients, totaling 86 cannulated veins. Median WUST preparation time was 55 [44–62] seconds and median time needed for each venous cannulation was 56 [36–71] seconds. A total of 84.9% of the veins were cannulated at the first attempt. There were 7 unsuccessful puncture attempts and 1 accidental arterial puncture. No pneumothorax, hemothorax, or nervous injury occurred in the 49 successfully cannulated patients. The unsuccessful one (distal subclavian occlusion) developed a minor local subcutaneous emphysema with no confirmed radiologic pneumothorax, not requiring intervention. During a follow‐up of 2.5 ± 1.1 months, a patient developed a pocket infection, with no other significant complications.Conclusion: Ultrasound‐guided axillary vein cannulation using a wireless transducer for the implantation of CIEDs is a feasible, fast, and safe method.
- Open Access
- 27 October 2015
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 18 (6) , 873-880
Impact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation
Aims The aim of this study was to determine the acute and long-term outcome of radiofrequency catheter ablation (RFCA) for cavotricuspid isthmus-dependent atrial flutter (CTI-AFL) in adults with and without previous cardiac surgery (PCS), and predictors of these outcomes. Structural alterations of the anatomical substrate of the CTI-AFL are observed in post-operative patients, and these may have an impact on the acute success of the ablation and in the long-term. Methods and results Clinical records of consecutive adults undergoing RFCA of CTI-AFL were analysed. Two main groups were considered: No PCS and PCS patients, who were further subdivided into acquired heart disease (AHD: ischaemic heart disease and valvular/mixed heart disease) and congenital heart disease [CHD: ostium secundum atrial septal defect (OS-ASD) and complex CHD]. Multivariate analysis identified clinical and procedural factors that predicted acute and long-term outcomes. A total of 666 patients (73% men, age 65 ± 12 years) were included: 307 of them with PCS. Ablation was successful in 647 patients (97%), 96% in the PCS group and 98% in the No PCS group (P = 0.13). Regression analysis showed that surgically corrected complex CHD was related to failure of the procedure [odds ratio 5.6; 95% confidence interval (CI) 1.6–18, P = 0.008]. After a follow-up of 45 ± 15 months, recurrences were observed in 90 patients (14%), more frequently in the PCS group: absolute risk of recurrence 18 vs. 10.5%, relative risk 1.71, 95% CI: 1.2–2.5, P = 0.006. Multivariate analysis indicated that the types of PCS [OS-ASD vs. No PCS: hazard ratio (HR) 2.57; 95% CI: 1.1–6.2, P = 0.03 and complex CHD vs. No PCS: HR 2.75; 95% CI: 1.41–5.48, P = 0.004], female gender (HR 1.55; 95% CI: 1.04–2.4, P = 0.048), and severe LV dysfunction (HR 1.36; 95% CI: 1.06–1.67, P = 0.04) were independent predictors of long-term recurrence. Conclusion Radiofrequency catheter ablation of CTI-AFL after surgical correction of AHD and CHD is associated with high acute success rates. The severity of the structural alterations of the underlying heart disease and consequently the type of surgical correction correlates with higher risk for recurrence.
- 27 October 2015
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 18 (6) , 873-880
Open AccessImpact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation
Aims The aim of this study was to determine the acute and long-term outcome of radiofrequency catheter ablation (RFCA) for cavotricuspid isthmus-dependent atrial flutter (CTI-AFL) in adults with and without previous cardiac surgery (PCS), and predictors of these outcomes. Structural alterations of the anatomical substrate of the CTI-AFL are observed in post-operative patients, and these may have an impact on the acute success of the ablation and in the long-term. Methods and results Clinical records of consecutive adults undergoing RFCA of CTI-AFL were analysed. Two main groups were considered: No PCS and PCS patients, who were further subdivided into acquired heart disease (AHD: ischaemic heart disease and valvular/mixed heart disease) and congenital heart disease [CHD: ostium secundum atrial septal defect (OS-ASD) and complex CHD]. Multivariate analysis identified clinical and procedural factors that predicted acute and long-term outcomes. A total of 666 patients (73% men, age 65 ± 12 years) were included: 307 of them with PCS. Ablation was successful in 647 patients (97%), 96% in the PCS group and 98% in the No PCS group (P = 0.13). Regression analysis showed that surgically corrected complex CHD was related to failure of the procedure [odds ratio 5.6; 95% confidence interval (CI) 1.6–18, P = 0.008]. After a follow-up of 45 ± 15 months, recurrences were observed in 90 patients (14%), more frequently in the PCS group: absolute risk of recurrence 18 vs. 10.5%, relative risk 1.71, 95% CI: 1.2–2.5, P = 0.006. Multivariate analysis indicated that the types of PCS [OS-ASD vs. No PCS: hazard ratio (HR) 2.57; 95% CI: 1.1–6.2, P = 0.03 and complex CHD vs. No PCS: HR 2.75; 95% CI: 1.41–5.48, P = 0.004], female gender (HR 1.55; 95% CI: 1.04–2.4, P = 0.048), and severe LV dysfunction (HR 1.36; 95% CI: 1.06–1.67, P = 0.04) were independent predictors of long-term recurrence. Conclusion Radiofrequency catheter ablation of CTI-AFL after surgical correction of AHD and CHD is associated with high acute success rates. The severity of the structural alterations of the underlying heart disease and consequently the type of surgical correction correlates with higher risk for recurrence.
- 26 October 2015
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 38 (12) , 1481-1484
Atypical Response to Diagnostic Maneuvers in a Narrow QRS Tachycardia: What is the Mechanism?
- 26 October 2015
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 38 (12) , 1481-1484
Atypical Response to Diagnostic Maneuvers in a Narrow QRS Tachycardia: What is the Mechanism?
- 1 June 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (12) , 1705-1713
Long-Term Outcome After Ablation of Right Atrial Tachyarrhythmias After the Surgical Repair of Congenital and Acquired Heart Disease
- 1 June 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (12) , 1705-1713
Long-Term Outcome After Ablation of Right Atrial Tachyarrhythmias After the Surgical Repair of Congenital and Acquired Heart Disease
- 8 September 2014
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 25 (12) , 1408-1410
Narrow QRS Tachycardia in a Patient with Spongiform Cardiopathy and Preexcitation: What is the Mechanism?
- 8 September 2014
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 25 (12) , 1408-1410
Narrow QRS Tachycardia in a Patient with Spongiform Cardiopathy and Preexcitation: What is the Mechanism?
- 1 May 2014
- Vol. 35 (18) , 1165-1166a
Catheter ablation of atrial fibrillation as first-line treatment: is the future here now?
- 1 May 2014
- Vol. 35 (18) , 1165-1166a
Catheter ablation of atrial fibrillation as first-line treatment: is the future here now?